Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C (2021)

First Author: Cooke G
Attributed to:  Stratified Medicine to Optimise Treatment for Hepatitis C Virus Infection funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.12688/wellcomeopenres.16594.1

Publication URI: http://dx.doi.org/10.12688/wellcomeopenres.16594.1

Type: Journal Article/Review

Parent Publication: Wellcome Open Research